Development of Tumor Organoids From Undifferentiated Primary Carcinomas to Guide Therapeutic Decisions

RecruitingOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

March 5, 2025

Primary Completion Date

December 15, 2027

Study Completion Date

December 15, 2031

Conditions
Undifferentiated Carcinoma
Interventions
OTHER

organoid etablishment

"Prior to initiation of 1st-line therapy:~* Collection of an additional study-specific tumor sample for tumoroid analysis (1 fresh tumor sample)~* A blood test blood a for tumoroid realization and :~* Analysis of ex vivo tumoroid response to treatment and correlation with patient response in vivo~* Analysis of correlation between in vivo and ex vivo tumor characteristics~* Analysis of first- and second-line survival rates and overall survival"

Trial Locations (1)

Unknown

RECRUITING

Centre François Baclesse, Caen

All Listed Sponsors
lead

Centre Francois Baclesse

OTHER